Get €500 (or $500) on your prepaid balance! Use it for premium subscriptions or job postings. Read more Close

The unique contributions of Rab11 and Rab35 to the completion of cell division.

Created on 29 Aug 2025

Authors

Paulius Gibieža, Emilija Ratkevičiūtė, Girstautė Dabkevičiūtė, Vilma Petrikaitė

Published in

Biological research. Volume 58. Issue 1. Pages 59. Aug 29, 2025. Epub Aug 29, 2025.

Abstract

Rab11 and Rab35 have been implicated in large-scale intracellular membrane trafficking during the last phases of the cell cycle. Although both proteins are associated with cytokinetic abscission, they appear to perform distinct functions and give rise to different phenotypes in dividing cells. Despite a substantial body of research on each protein individually, no study to date has systematically compared Rab11 and Rab35 in the context of cancer cell division. As a result, the extent of their interrelationship and potential compensatory mechanisms remains unclear. Our data demonstrate that Rab11a, Rab11b and Rab35 expression levels are partially interrelated. We also show that Rab11 and Rab35 contribute to mitotic progression in different ways, particularly during specific stages of the M-phase. Notably, depletion of either Rab11 or Rab35 disrupts cytokinetic abscission and correlates with aberrant F-actin accumulation at the intercellular bridge. Furthermore, overexpression of related Rab proteins with overlapping functions does not rescue the cytokinetic defects caused by Rab11 or Rab35 downregulation in cancer cells. Therefore, this study aims to deepen our understanding of how Rab11 and Rab35 orchestrate the molecular events that drive the progression from late anaphase through the completion of cytokinesis.

PMID:
40877912
Bibliographic data and abstract were imported from PubMed on 29 Aug 2025.

Read full publication at:
Please sign in to see all details.

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Loading ad...